Starting Atomoxetine at 10mg Twice Daily is NOT Appropriate
No, starting atomoxetine at 10mg twice daily (20mg total daily dose) is below the FDA-approved initial dosing and may lead to suboptimal treatment outcomes.
FDA-Approved Initial Dosing
The FDA label provides clear weight-based starting doses 1:
For children and adolescents ≤70 kg:
- Start at 0.5 mg/kg/day total daily dose
- Increase after minimum 3 days to target of 1.2 mg/kg/day
- Can be given once daily or divided twice daily
For children and adolescents >70 kg and adults:
- Start at 40 mg/day total daily dose
- Increase after minimum 3 days to target of 80 mg/day
- Can be given once daily or divided twice daily
Why 10mg Twice Daily is Problematic
A 10mg twice daily regimen (20mg total) would only be appropriate for a child weighing approximately 40 kg or less as an initial dose. For most patients, this represents underdosing that:
- Falls below the 0.5 mg/kg/day starting threshold for patients >40 kg
- Significantly undershoots the therapeutic target of 1.2 mg/kg/day
- May lead to premature treatment discontinuation due to perceived lack of efficacy 2
Optimal Titration Strategy
The evidence strongly supports slow, twice-daily titration to minimize adverse effects 3:
- Twice-daily dosing with gradual titration over 2 weeks reduces early adverse events compared to rapid once-daily titration
- Specifically decreases somnolence (4.2% vs 14.3%) and decreased appetite (8.0% vs 14.3%)
- The guideline explicitly warns that "initial somnolence and gastrointestinal symptoms" occur "particularly if the dosage is increased too rapidly" 4
Clinical Algorithm for Starting Atomoxetine
- Calculate weight-based starting dose: 0.5 mg/kg/day
- Choose twice-daily divided dosing (morning and late afternoon/evening) to minimize GI side effects
- Wait minimum 3 days, then increase to target 1.2 mg/kg/day
- If inadequate response after 2-4 additional weeks, may increase to maximum 1.4 mg/kg/day (not to exceed 100mg total) in children/adolescents
Common Pitfall to Avoid
Do not start at arbitrarily low doses like 10mg twice daily without weight-based calculation. Research demonstrates that adults who never reached the recommended 80mg dose had significantly shorter treatment duration (65.6 vs 159.3 days) 2. Starting too low may result in:
- Inadequate symptom control
- Patient/family perception of treatment failure
- Premature discontinuation before reaching therapeutic doses
Special Dosing Adjustments
Reduce initial and target doses by 50% for moderate hepatic impairment or when using strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) 1.